Business
AstraZeneca and Johnson & Johnson given green light to resume US coronavirus vaccine trials – ABC News
In a sign of progress in the race to develop a vaccine for COVID-19, AstraZeneca’s resumption of its US clinical trial is set to be soon followed by Johnson & Johnson…
AstraZeneca has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week.
Key points:
- Both vaccine candidates had been forced to pause US trials after participant illnesses
- But both have been cleared to resume after it was found the vaccines were not the cause
- The race for a vaccine comes as coronavirus infections rise in dozens of countries
The news signalled progress against the novel coronavirus…
Continue Reading
-
Noosa News8 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News9 hours agoMotorcyclist dies in crash with truck
-
Noosa News24 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General23 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate